Categories News Press Releases Archives 2025 November October September August July June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November September August June May March February January 2021 December November October September August May April February Nov 03 U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d) Read More Share:| | |